A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
Trial details
- Registry ID
- NCT06419205
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3GNCT06419205 | Akebia Therapeutics | Phase 2 | Recruiting | 2028-02Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |